About Casper Pharma
Casper Pharma is a company based in East Brunswick (United States) founded in 2016 was acquired by Suven Pharmaceuticals in April 2022. It operates as a Direct-to-Consumer (D2C), and B2B2C. Casper Pharma offers products and services including Triglide, Gastrointestinal Therapies, Urological Medications, Pain Management Solutions, and Ophthalmic Treatments.
- Headquarter East Brunswick, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
$1.24 M (USD)526as on Mar 31, 2022
-
Net Profit
$-1.96 M (USD)-117as on Mar 31, 2022
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Suven Pharmaceuticals
(Apr 05, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Casper Pharma
Casper Pharma offers a comprehensive portfolio of products and services, including Triglide, Gastrointestinal Therapies, Urological Medications, Pain Management Solutions, and Ophthalmic Treatments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Medication developed for cardiovascular health management and treatment.
Therapies provided for gastrointestinal conditions and patient care.
Medications offered for urological issues and health improvement.
Solutions created for pain management and patient relief.
Treatments designed for ophthalmic conditions and vision care.
Funding Insights of Casper Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Casper Pharma
Casper Pharma has secured backing from 1 investor. Prominent investors backing the company include Suven Pharma. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Contract manufacturing and development of APIs and formulations are provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Casper Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Casper Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Casper Pharma Comparisons
Competitors of Casper Pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Casper Pharma
When was Casper Pharma founded?
Casper Pharma was founded in 2016.
Where is Casper Pharma located?
Casper Pharma is headquartered in East Brunswick, United States. It is registered at East Brunswick, New Jersey, United States.
What is the annual revenue of Casper Pharma?
Annual revenue of Casper Pharma is $1.24M as on Mar 31, 2022.
What does Casper Pharma do?
Casper Pharma is engaged in the development, acquisition, and commercialization of specialty pharmaceuticals aimed at improving patient lives. The company operates within cardiovascular, gastrointestinal, urological, pain management, and ophthalmic markets. Solutions are provided through a global network, leveraging innovation and technology to address unmet medical needs. A commitment to high-quality, cost-effective therapies is maintained to serve healthcare communities and enhance patient outcomes.
What products or services does Casper Pharma offer?
Casper Pharma offers Triglide, Gastrointestinal Therapies, Urological Medications, Pain Management Solutions, and Ophthalmic Treatments.
Who are Casper Pharma's investors?
Casper Pharma has 1 investor. Key investors include Suven Pharma.